BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okuda R, Hagiwara E, Katano T, Ikeda S, Sekine A, Kitamura H, Baba T, Okudela K, Ohashi K, Ogura T. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome. Sarcoidosis Vasc Diffuse Lung Dis 2019;36:39-46. [PMID: 32476935 DOI: 10.36141/svdld.v36i1.7117] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Lee JH, Jang JH, Park JH, Jang HJ, Park CS, Lee S, Kim SH, Kim JY, Kim HK. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases. PLoS One 2021;16:e0255365. [PMID: 34314462 DOI: 10.1371/journal.pone.0255365] [Reference Citation Analysis]
2 Oh JY, Lee YS, Min KH, Hur GY, Lee SY, Kang KH, Shim JJ. Impact and prognosis of lung cancer in patients with combined pulmonary fibrosis and emphysema. Sarcoidosis Vasc Diffuse Lung Dis 2020;37:e2020020. [PMID: 33597805 DOI: 10.36141/svdld.v37i4.7316] [Reference Citation Analysis]